Prognostic index for patients with parotid carcinoma: External validation using the nationwide 1985-1994 Dutch head and neck oncology cooperative group database

Cancer

Volumn 97, Issue 6, 2003, Pages 1453-1463

  Vander Poorten, Vincent L M ^a,b   Hart, Augustinus A M ^a   Van der Laan, Bernardus F A M ^c   Baatenburg de Jong, Robert J ^d   Manni, Johannes J ^e   Marres, Henri A M ^f   Meeuwis, Cees A ^g   Lubsen, Herman ^h   Terhaard, Chris H J ^h   Balm, Alfonsus J M ^a,i  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Parotid carcinoma; Prognostic factors; Prognostic index; Salivary gland neoplasm; Validation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER SURVIVAL; DATA BASE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NETHERLANDS; PAROTID GLAND CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; CARCINOMA; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PAIN; PAROTID NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE VALUES; SKIN NEOPLASMS;

EID: 0037443705     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11254     Document Type: Article

References (34)

1. Visser O, Coebergh JWW, Otter R, Schouten LJ. Salivary glands. In: Visser O, Coebergh JWW, Otter R, Schouten LJ. Head and neck tumours in the Netherlands 1989-1995. Utrecht: The Netherlands Cancer Registry - Association of Comprehensive Cancer Centres, 1998:16-18.
2. Cox DR. Regression models and life tables (with discussion). J R Stat Soc [B]. 1972;34:187-202.
3. Vander Poorten VLM, Balm AJM, Hilgers FJM, et al. The development of a prognostic score for patients with parotid carcinoma. Cancer. 1999;85:2057-2067.
4. Eypasch E. Surgical examples of scoring systems. In: Troidl H, McNeally MF, Mulder DS, Wechsler AS, McPeek B, Spitzer WO. Surgical research. Basic principles and clinical practice. 3rd edition. New York: Springer-Verlag, 1998:283-292.
5. International Union Against Cancer. UICC TNM atlas: illustrated guide to the TNM/pTNM classification of malignant tumours. 3rd edition. 2nd revision. Berlin:Springer-Verlag, 1992:50-55.
6. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med. 2000;19:453-473.
7. van Houwelingen JC, Le Cessie S. Predictive value of statistical models. Stat Med. 1990;9:1303-1325.
8. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999;130: 515-524.
9. Seifert G, Sobin LH. The World Health Organization's histological classification of salivary gland tumors. A commentary on the second edition. Cancer. 1992;70:379-385.
10. Seifert G, Brocheriou C, Cardesa A, Eveson JW. WHO international histological classification of tumours. Tentative histological classification of salivary gland tumours. Pathol Res Pract. 1990;186:555-581.
11. Hart AAM, Strobbe LJA, Jonk A, Nieweg OE, Kroon BBR. A new prognostic index for surgically treated stage III melanoma patients. In: Strobbe LJA, editor. Regional metastatic melanoma. Aspects of treatment and prognostic factors. Nijmegen, the Netherlands: BENDA drukkers, Nijmegen, 2001:123-150.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
13. Harrell FE, Lee KL, Mark DB. Tutorial in biostatistics. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
14. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239-241.
15. Therneau TM, Grambsch PM, Fleming TR. Martingale-based residuals for survival models. Biometrika. 1990;77:147-160.
16. Peto R, Pike MC, Breslow NE, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II: Analysis and examples. Br J Cancer. 1977;35:1-39.
17. Thacknam AC, Sobin LH. World Health Organization: International histological classification of tumors. No. 7: histological typing of salivary gland tumors. Geneva: World Health Organization, 1972:3-27.
18. Parry J, Cummins C, Redman V, Wilson S, Woodman C. Incidence and survival of malignant parotid tumours in the West Midlands region 1977-1986. Clin Oncol (R Coll Radiol). 1993;5:150-153.
19. Poulsen MG, Pratt GR, Kynaston B, Tripcony LB. Prognostic variables in malignant epithelial tumors of the parotid. Int J Radiat Oncol Biol Phys. 1992;23:327-332.
20. North CA, Lee DJ, Piantadosi S, Zahurak M, Johns ME. Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 1990;18:1319-1326.
21. Witten J, Hybert F, Hansen HS. Treatment of malignant tumors in the parotid glands. Cancer. 1990;65:2515-2520.
22. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck. 1986;8:177-184.
23. Regis de Brito Santos I, Kowalski LP, Cavalcante de Araujo V, Flavia Logullo A, Magrin J. Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. Arch Otolaryngol Head Neck Surg. 2001;127: 56-60.
24. Spiro IJ, Wang CC, Montgomery WW. Carcinoma of the parotid gland. Analysis of treatment results and patterns of failure after combined surgery and radiation therapy. Cancer. 1993;71:2699-2705.
25. Magnano M, Gervasio CF, Cravero L, et al. Treatment of malignant neoplasms of the parotid gland. Otolaryngol Head Neck Surg. 1999;121:627-632.
26. Numata T, Muto H, Shiba K, Nagata H, Terada N, Konno A. Evaluation of the validity of the 1997 International Union Against Cancer TNM classification of major salivary gland carcinoma. Cancer. 2000;89:1664-1669.
27. Mackillop WJ. The importance of prognosis in cancer medicine. In: Gospodarowicz MK, Henson DE, Hutter RVP, O'Sullivan B, Sobin LH, Wittekind Ch, editors. Prognostic factors in cancer. 2nd edition. New York: Wiley-Liss, 2001: 3-16.
28. Charlson ME, Ales KL, Simon R, MacKenzie CR. Why predictive indexes perform less well in validation studies. Is it magic or methods? Arch Intern Med. 1987;147:2155-2161.
29. van Houwelingen HC. Validation, calibration, revision and combination of prognostic survival models. Stat Med. 2000;19:3401-3415.
30. Dukes CE, Bussey HJR. The spread of rectal cancer and its effect on prognosis. Br J Cancer. 1958;12:309-320.
31. Jass JR, Love SB, Northover JMA. A new prognostic classification of rectal cancer. Lancet. 1987;1:1303-1306.
32. Harrison JC, Dean PJ, el Zeky F, Vander Zwaag R. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol. 1994;25:498-505.
33. Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology [editorial]. Br J Cancer. 1994;69:979-985.
34. Windeler J. Prognosis - what does the clinician associate with this notion? Stat Med. 2000;19:425-430.